News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
DexCom Says gets FDA Approval for Glucose Monitoring Device
June 1, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
May 31 (Reuters) - DexCom Inc. said U.S. regulators approved its seven-day continuous glucose monitoring device for people with diabetes.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Obesity
Lilly’s new obesity pill linked to ‘serious’ safety signals, FDA requests more data
April 15, 2026
·
2 min read
·
Tristan Manalac
Podcast
J&J targets $100B revenue, Replimune rebuffed again and a “Revolution” in pancreatic cancer
April 15, 2026
·
1 min read
·
Heather McKenzie
Gene editing
FDA bolsters bespoke therapy framework with new draft safety guidelines
April 14, 2026
·
2 min read
·
Gabrielle Masson
Approvals
Travere’s Filspari overcomes Phase 3 fail to become first drug for rare kidney disease
April 14, 2026
·
2 min read
·
Tristan Manalac